Trial intelligence / Profile preview

ASCs and Vitamin D in Recent-onset Type 1 Diabetes

NCT03920397Completed

Sponsor
Federal University of Rio de Janeiro
Start
Mar 2015
Primary completion
Mar 2021
Countries
1
01

Overview

Open-label trial in type 1 diabetes mellitus (T1D) (3 arms), sponsored by Federal University of Rio de Janeiro. Primary endpoints: Peak response of C-peptide after mixed meal test at 24 months and Glycated hemoglobin at 24 months. Started Mar 2015; status: completed.

02

Conditions

type 1 diabetes mellitus (T1D)

Beyond the preview

Go deeper on NCT03920397.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT03920397.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call